Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Biotest AG
Headquarters: Dreieich, Germany
Website: N/A
Year Founded: 1946
Status: Acquired
BioCentury | May 8, 2020
Product Development
Japanese approval for Gilead’s remdesivir
Plus Plasma Alliance partners with NIAID; and three Chinese biotechs join to make antibody therapy
BioCentury | Apr 30, 2020
Product Development
Alliance advancing unbranded hyperimmune globulin product for COVID-19
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Apr 7, 2020
Product Development
COVID-19 roundup: Inovio starts vaccine trial; plus updates from RedHill, Hope, CytoDyn, Gilead, Takeda, AACR and UNC-Emory
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Oct 11, 2018
Strategy
Border security for China’s genomes
Balancing protection and translation for China’s genomic data troves
BioCentury | Jun 28, 2018
Politics & Policy
Broader CFIUS jurisdiction may have implications for biotech
BioCentury | Nov 10, 2017
Company News
Biotest's Chinese takeover tripped up by U.S. security concerns
Items per page:
1 - 10 of 58